Skip to main content

Day: January 16, 2025

Beam Global to Participate at the 2025 Sequire Investor Summit in Puerto Rico

Beam Global-Sequire Investor SummitBeam Global-Sequire Investor SummitSAN DIEGO, CA, Jan. 16, 2025 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy security, announced today that Desmond Wheatley, Chief Executive Officer, will participate in the Sequire Investor Summit in San Juan, Puerto Rico. Location: Condado Vanderbilt Hotel (Fauno East), Puerto Rico Presentation Date: January 22, 2025 Time: 15:00PM – 15:30PM AST Mr. Wheatley will lead a group presentation and will additionally be available for one-on-one meetings with registered conference attendees. To request a meeting, please use this link to register for the conference: https://puertorico.srax.com/ or contact Luke Higgins at Beam...

Continue reading

Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial

ONS-5010 demonstrated to be non-inferior to Lucentis at 12 weeks BLA resubmission on track for calendar Q1 2025 Entered into agreements for warrant inducement transaction expected to result in up to $20.4 million in gross proceedsISELIN, N.J., Jan. 16, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Outlook Therapeutics, or the Company) (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom for the first authorized use of an ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD), today announced it has completed the analysis of the complete 12-week safety and efficacy results for NORSE EIGHT, the second of two adequate and well controlled clinical trials evaluating ONS-5010 in wet AMD patients. ONS-5010...

Continue reading

Information mensuelle relative au nombre total de droit de vote Décembre 2024

HF COMPANYSociété Anonyme au capital de 1 569 130.50 eurosSiège social : 14 Rue Dora Maar – 37100 TOURS405 250 119 RCS TOURS Information mensuelle relative au nombre total de droits de voteet d’actions composant le capital social Article L 233-8 II du Code de commerce et article 222-12-5 du règlement général de l’AMF Dénomination sociale de l’émetteur : HF COMPANY14, Rue Dora Maar37 100 TOURSDate d’arrêté des Nombre total d’actions Nombre total de droits de voteInformations Composant le capital  31 décembre 2024 3 138 261 Total brut de droits de vote : 4 199 196    Total net* de droits de vote : 3 896 826* Total net = nombre total de droits de vote attachés aux actions – actions privées du droit de vote.AttachmentInformationMensuellesdecembre2024

Continue reading

Huize Launches Customized Mid-Tier Medical Insurance Product “PrimeMed” in Partnership with CCIC and MSH CHINA

SHENZHEN, China, Jan. 16, 2025 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in Asia, today announced the launch of “PrimeMed”, a customized mid-tier medical insurance product, in collaboration with China Continent Property & Casualty Insurance Co., Ltd. (CCIC) and MSH CHINA Enterprise Services Co., Ltd. (MSH CHINA). Designed to provide scarce, high-cost medical resources such as specialized and international departments in public hospitals and designated private medical institutions, this new solution addresses the need for flexible and affordable insurance coverage. “PrimeMed”’s key features include:Flexible deductibles:...

Continue reading

Share Buyback Transaction Details January 9 – January 15, 2025

PRESS RELEASE                                         Share Buyback Transaction Details January 9 – January 15, 2025 Alphen aan den Rijn – January 16, 2025 – Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 79,801 of its own ordinary shares in the period from January 9, 2025, up to and including January 15, 2025, for €13.2 million and at an average share price of €164.82. These repurchases are part of the share buyback program announced on October 30, 2024, under which we intend to repurchase shares for €100 million during the period starting January 2, 2025, up to and including February 24, 2025. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2025Period Cumulative shares...

Continue reading

Elis: Half-yearly report relative to the liquidity contract as of 31 December 2024

Half-yearly report relative to the liquidity contract Under the liquidity contract entered between Elis and Oddo BHF (Group Natixis), the following resources appeared on the liquidity account on December 31st, 2024:184,390 shares €1,531,816 In the 2nd half of 2024, the following resources were traded:On buy side, 1,635,873 shares for €33,206,130 (6,722 executions) On sell side, 1,619,744 shares for €33,168,052 (3,765 executions) As a reminder: 1)   The following resources appeared on the last half year statement on June 30, 2024 on the liquidity account:168,261 shares €1,569,8942)   In the 1st half of 2024, the following resources were traded:On buy side, 1,487,328 shares for €31,275,739 (4,324 executions) On sell side, 1,382,259 shares for €29,145,640 (3,418 executions)3)   The following resources appeared on the liquidity...

Continue reading

Member of the Board, Lars Christian Tofft, has suddenly passed away

Noerresundby, Denmark, 16 January 2025Announcement no. 02/2025It is with sadness that we have to announce that member of our board, Lars Christian Tofft, has passed away. Lars Christian Tofft has been a member of RTX’s board since 2017, and he has actively contributed to the company’s strategy and development. His straightforward and constructive approach has always been value-creating and appreciated by the board. Best regards,RTX A/S Peter Thostrup        Chair of the BoardAttachmentRTX CA No 02-2025 – 16.01.25 – Death

Continue reading

DSV – 2024 Annual Report conference call

We expect to release the 2024 Annual Report of DSV A/S in the morning of 4 February 2025. A webcast and conference call will be held at 11:00 am CET. At the call, Group CEO Jens H. Lund and Group CFO Michael Ebbe will present the 2024 Annual Report. The presentation will be followed by a Q&A session. Date:                 4 February 2025Time:                 11:00 am CET To attend the webcast presentation, please go to Webcast presentation – DSV Annual Report 2024 or https://investor.dsv.com/. If you would like to ask questions during the conference call, please register through this link: Conference call Q&A – DSV Annual Report 2024. You will receive an email with dial-in telephone numbers. We recommend participants to dial in 10 minutes prior to the scheduled start time. Contacts Investor RelationsStig Frederiksen,...

Continue reading

Armstrong International Acquires HygroTemp to Expand De-steamed Humidification Solutions

Armstrong International – EMEA has acquired HygroTemp, a Netherlands-based leader in humidity control solutions HERSTAL, Belgium, Jan. 16, 2025 (GLOBE NEWSWIRE) — Armstrong International – Europe/Middle East/Africa (EMEA), the continental entity of the global thermal energy solutions provider Armstrong International, has acquired HygroTemp, a Netherlands-based leader in humidity control solutions. HygroTemp has worked closely with Armstrong – EMEA’s Humidification Group in the Netherlands since 2007. Together they promote key technologies like the EvaPack™, a hygienic and controlled evaporation solution manufactured by Armstrong EMEA’s subsidiary, Devatec, located in Normandy (France).HygroTemp’s former owner and managing director, Rolf Bosscher, will support Armstrong’s European Humidification team in further developing...

Continue reading

Stellantis Reports Q4 2024 Consolidated Shipment Estimates

Stellantis Reports Q4 2024 Consolidated Shipment Estimates -9% Q4 y-o-y decline in shipments improved vs. -20% in Q3, as inventory reduction actions concluded and new product launches in Europe reduced gaps in the Company’s offering related to our generational portfolio transition  AMSTERDAM, January 16, 2025 – Stellantis N.V. today published global quarterly consolidated shipment estimates and provided commentary on related business trends. The term shipments describes volumes of vehicles delivered to our dealers, distributors, or directly from the Company to retail and fleet customers, which directly drive revenue recognition. Consolidated shipments for the three months ending December 31, 2024, were an estimated 1,395 thousand units, representing a 9% decline versus the same period in 2023. The shipment performance directionally converged...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.